Grantham, Mayo, Van Otterloo & Co (GMO)’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
MIP
Grantham, Mayo, Van Otterloo & Co (GMO)'s SNY Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Sanofi (SNY) stake by 93% in Q1 2026, buying an estimated $4.24M and bringing the position to 189,071 shares worth $9.11M. The position accounts for 0.02% of the portfolio, ranked #250.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SNY in Q1 2018 and has held it in 18 quarters since. The position peaked at $26.8M in Q3 2019. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 189,071 shares of Sanofi worth $9.11M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 90,900 Sanofi shares in Q1 2026, an estimated $4.24M.
- Sanofi made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #250 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Sanofi in Q1 2018 and has held it in 18 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Sanofi position peaked at $26.8M in Q3 2019.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.